Cargando…

Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus

BACKGROUND: There have been few reports on children who developed common variable immunodeficiency (CVID) in association with immunoglobulin A (IgA) and IgG2 deficiencies and systemic lupus erythematosus (SLE). CASE-DIAGNOSIS/TREATMENT: Our patient experienced nephrotic syndrome and acute respirator...

Descripción completa

Detalles Bibliográficos
Autores principales: Suyama, Kazuhide, Kawasaki, Yukihiko, Abe, Yusaku, Watanabe, Masahiro, Ohara, Shinichiro, Oikawa, Tomoko, Sakai, Nobuko, Hashimoto, Kouichi, Hosoya, Mitsuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101897/
https://www.ncbi.nlm.nih.gov/pubmed/22207346
http://dx.doi.org/10.1007/s00467-011-2063-y
_version_ 1783511716146970624
author Suyama, Kazuhide
Kawasaki, Yukihiko
Abe, Yusaku
Watanabe, Masahiro
Ohara, Shinichiro
Oikawa, Tomoko
Sakai, Nobuko
Hashimoto, Kouichi
Hosoya, Mitsuaki
author_facet Suyama, Kazuhide
Kawasaki, Yukihiko
Abe, Yusaku
Watanabe, Masahiro
Ohara, Shinichiro
Oikawa, Tomoko
Sakai, Nobuko
Hashimoto, Kouichi
Hosoya, Mitsuaki
author_sort Suyama, Kazuhide
collection PubMed
description BACKGROUND: There have been few reports on children who developed common variable immunodeficiency (CVID) in association with immunoglobulin A (IgA) and IgG2 deficiencies and systemic lupus erythematosus (SLE). CASE-DIAGNOSIS/TREATMENT: Our patient experienced nephrotic syndrome and acute respiratory distress syndrome (ARDS) caused by influenza A/H1N1 virus infection at 5 years of age. A diagnosis of IgA and IgG2 deficiency and SLE was made on the basis of severe proteinuria, hematuria, hypocomplementemia, high anti-DNA antibody and antinuclear antibody (ANA) titers, and malar rash. However, these clinical signs and symptoms and laboratory features disappeared after the administration of methylprednisolone pulse therapy and prednisolone. For the 5 years following the initial treatment for SLE, the patient experienced a number of infections and had a low serum total IgG level; she was eventually diagnosed with CVID. The administration of intravenous immunoglobulin (IVIG) was required to prevent subsequent infections, and no relapse of SLE was observed. CONCLUSION: We report the development of CVID in an IgA- and IgG2-deficient patient with SLE on the basis of multiple episodes of infection. To prevent the development of CVID in IgA- and IgG2-deficient patients with SLE, it is important to prevent immune dysregulation by the avoidance of infections through the use of IVIG therapy.
format Online
Article
Text
id pubmed-7101897
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-71018972020-03-31 Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus Suyama, Kazuhide Kawasaki, Yukihiko Abe, Yusaku Watanabe, Masahiro Ohara, Shinichiro Oikawa, Tomoko Sakai, Nobuko Hashimoto, Kouichi Hosoya, Mitsuaki Pediatr Nephrol Brief Report BACKGROUND: There have been few reports on children who developed common variable immunodeficiency (CVID) in association with immunoglobulin A (IgA) and IgG2 deficiencies and systemic lupus erythematosus (SLE). CASE-DIAGNOSIS/TREATMENT: Our patient experienced nephrotic syndrome and acute respiratory distress syndrome (ARDS) caused by influenza A/H1N1 virus infection at 5 years of age. A diagnosis of IgA and IgG2 deficiency and SLE was made on the basis of severe proteinuria, hematuria, hypocomplementemia, high anti-DNA antibody and antinuclear antibody (ANA) titers, and malar rash. However, these clinical signs and symptoms and laboratory features disappeared after the administration of methylprednisolone pulse therapy and prednisolone. For the 5 years following the initial treatment for SLE, the patient experienced a number of infections and had a low serum total IgG level; she was eventually diagnosed with CVID. The administration of intravenous immunoglobulin (IVIG) was required to prevent subsequent infections, and no relapse of SLE was observed. CONCLUSION: We report the development of CVID in an IgA- and IgG2-deficient patient with SLE on the basis of multiple episodes of infection. To prevent the development of CVID in IgA- and IgG2-deficient patients with SLE, it is important to prevent immune dysregulation by the avoidance of infections through the use of IVIG therapy. Springer-Verlag 2011-12-30 2012 /pmc/articles/PMC7101897/ /pubmed/22207346 http://dx.doi.org/10.1007/s00467-011-2063-y Text en © IPNA 2011 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Brief Report
Suyama, Kazuhide
Kawasaki, Yukihiko
Abe, Yusaku
Watanabe, Masahiro
Ohara, Shinichiro
Oikawa, Tomoko
Sakai, Nobuko
Hashimoto, Kouichi
Hosoya, Mitsuaki
Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus
title Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus
title_full Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus
title_fullStr Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus
title_full_unstemmed Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus
title_short Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus
title_sort development of common variable immunodeficiency in iga- and igg2-deficient patients with systemic lupus erythematosus
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101897/
https://www.ncbi.nlm.nih.gov/pubmed/22207346
http://dx.doi.org/10.1007/s00467-011-2063-y
work_keys_str_mv AT suyamakazuhide developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT kawasakiyukihiko developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT abeyusaku developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT watanabemasahiro developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT oharashinichiro developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT oikawatomoko developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT sakainobuko developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT hashimotokouichi developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus
AT hosoyamitsuaki developmentofcommonvariableimmunodeficiencyinigaandigg2deficientpatientswithsystemiclupuserythematosus